For instance, overexpression of TRIM22 has been shown to decrease the proliferation and migration of endometrial cancer cells as knockdown of TRIM22 was found to accelerate cancer progression via NOD‐NF‐κB pathway.182. This evidence concerns the gene TRIM22 and endometrial cancer.